Comparison between adults and children with Henoch–Schönlein purpura nephritis

go back to reference Saulsbury FT (2007) Clinical update: Henoch–Schönlein purpura. Lancet 369:976–978CrossRefPubMed Saulsbury FT (2007) Clinical update: Henoch–Schönlein purpura. Lancet 369:976–978CrossRefPubMed

go back to reference Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920CrossRefPubMedCentralPubMed Narchi H (2005) Risk of long term renal impairment and duration of follow up recommended for Henoch–Schönlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 90:916–920CrossRefPubMedCentralPubMed

go back to reference Mir S, Yavascan O, Mutluba F, Yeniay B, Sonmez F (2007) Clinical outcome in children with Henoch- Schönlein nephritis. Pediatr Nephrol 22:64–70CrossRefPubMed Mir S, Yavascan O, Mutluba F, Yeniay B, Sonmez F (2007) Clinical outcome in children with Henoch- Schönlein nephritis. Pediatr Nephrol 22:64–70CrossRefPubMed

go back to reference Rai A, Nast C, Adler S (1999) Henoch–Schönlein purpura nephritis. J Am Soc Nephrol 10:2637–2644PubMed Rai A, Nast C, Adler S (1999) Henoch–Schönlein purpura nephritis. J Am Soc Nephrol 10:2637–2644PubMed

go back to reference García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA (2002) Henoch–Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32:149–156CrossRefPubMed García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA (2002) Henoch–Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum 32:149–156CrossRefPubMed

go back to reference Guo YN, Wang Z, Lu J (2013) The relationship between children kidney diseases and adult ESRD—an epidemiological investigation of 700 cases. Ren Fail 35:1353–1357CrossRefPubMed Guo YN, Wang Z, Lu J (2013) The relationship between children kidney diseases and adult ESRD—an epidemiological investigation of 700 cases. Ren Fail 35:1353–1357CrossRefPubMed

go back to reference Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein–Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823CrossRefPubMed Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein–Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823CrossRefPubMed

go back to reference Fogazzi GB, Pasquali S, Moriggi M, Casanova S, Damilano I, Mihatsch MJ, Zucchelli P, Ponticelli C (1989) Long-term outcome of Schönlein–Henoch nephritis in the adult. Clin Nephrol 31:60–66PubMed Fogazzi GB, Pasquali S, Moriggi M, Casanova S, Damilano I, Mihatsch MJ, Zucchelli P, Ponticelli C (1989) Long-term outcome of Schönlein–Henoch nephritis in the adult. Clin Nephrol 31:60–66PubMed

go back to reference Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch–Schönlein nephritis. Pediatr Nephrol 25:1101–1108CrossRefPubMed Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch–Schönlein nephritis. Pediatr Nephrol 25:1101–1108CrossRefPubMed

go back to reference Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL (2009) Clinical manifestations and outcomes of Henoch–Schönlein purpura: comparison between adults and children. Pediatr Neonatol 50:162–168CrossRefPubMed Hung SP, Yang YH, Lin YT, Wang LC, Lee JH, Chiang BL (2009) Clinical manifestations and outcomes of Henoch–Schönlein purpura: comparison between adults and children. Pediatr Neonatol 50:162–168CrossRefPubMed

go back to reference Uppal SS, Hussain MA, Al-Raqum HA, Nampoory MR, Al-Saeid K, Al-Assousi A, Abraham M, Malaviya AN (2006) Henoch–Schönlein’s purpura in adults versus children/adolescents: a comparative study. Clin Exp Rheumatol 24:S26–S30PubMed Uppal SS, Hussain MA, Al-Raqum HA, Nampoory MR, Al-Saeid K, Al-Assousi A, Abraham M, Malaviya AN (2006) Henoch–Schönlein’s purpura in adults versus children/adolescents: a comparative study. Clin Exp Rheumatol 24:S26–S30PubMed

go back to reference Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, García-Fuentes M, González-Gay MA (1997) Henoch–Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864CrossRefPubMed Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, García-Fuentes M, González-Gay MA (1997) Henoch–Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome. Arthritis Rheum 40:859–864CrossRefPubMed

go back to reference Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO) (2010) EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis 69:798–806CrossRefPubMed

go back to reference Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W (2014) Henoch–Schönlein purpura in 535 Chinese children: clinical features and risk factors for renal involvement. J Int Med Res 42:1043–1049CrossRefPubMed Mao Y, Yin L, Huang H, Zhou Z, Chen T, Zhou W (2014) Henoch–Schönlein purpura in 535 Chinese children: clinical features and risk factors for renal involvement. J Int Med Res 42:1043–1049CrossRefPubMed

go back to reference Halling SF, Soderberg MP, Berg UB (2005) Henoch–Schönlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 20:46–51CrossRefPubMed Halling SF, Soderberg MP, Berg UB (2005) Henoch–Schönlein nephritis: clinical findings related to renal function and morphology. Pediatr Nephrol 20:46–51CrossRefPubMed

go back to reference Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedCentralPubMed Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637CrossRefPubMedCentralPubMed

go back to reference World Health Organization Expert Committee (1996) Hypertension control. WHO Expert Committee, Geneva World Health Organization Expert Committee (1996) Hypertension control. WHO Expert Committee, Geneva

go back to reference Appel GB, Radhakrish J, D’Agati VD (2004) Secondary glomerular disease. In: Brenner BM (ed) The kidney, 7th edn. Saunders, Philadelphia, pp 1381–1482 Appel GB, Radhakrish J, D’Agati VD (2004) Secondary glomerular disease. In: Brenner BM (ed) The kidney, 7th edn. Saunders, Philadelphia, pp 1381–1482

go back to reference Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375CrossRefPubMed Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch–Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375CrossRefPubMed

go back to reference Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet 360:666–670CrossRefPubMed Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch–Schönlein purpura: a retrospective cohort study. Lancet 360:666–670CrossRefPubMed

go back to reference Zhang L, Han C, Sun C, Meng H, Ye F, Na S, Chen F, Zhang D, Jin X (2013) Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch–Schönlein purpura nephritis. Transl Res 161:26–36CrossRefPubMed Zhang L, Han C, Sun C, Meng H, Ye F, Na S, Chen F, Zhang D, Jin X (2013) Serum levels of alpha-smooth muscle actin and c-Met as biomarkers of the degree of severity of Henoch–Schönlein purpura nephritis. Transl Res 161:26–36CrossRefPubMed

go back to reference Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278CrossRefPubMed Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch–Schönlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278CrossRefPubMed

go back to reference Shenoy M, Bradbury MG, Lewis MA, Webb NJ (2007) Outcome of Henoch–Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22:1717–1722CrossRefPubMed Shenoy M, Bradbury MG, Lewis MA, Webb NJ (2007) Outcome of Henoch–Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22:1717–1722CrossRefPubMed

go back to reference Nickavar A, Mehrazma M, Lahouti A (2012) Clinicopathologic correlations in Henoch–Schönlein nephritis. Iran J Kidney Dis 6:437–440PubMed Nickavar A, Mehrazma M, Lahouti A (2012) Clinicopathologic correlations in Henoch–Schönlein nephritis. Iran J Kidney Dis 6:437–440PubMed

go back to reference Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, Hosoya M (2013) Henoch–Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 59:15–26CrossRefPubMed Kawasaki Y, Ono A, Ohara S, Suzuki Y, Suyama K, Suzuki J, Hosoya M (2013) Henoch–Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment. Fukushima J Med Sci 59:15–26CrossRefPubMed

go back to reference Tudorache E, Azema C, Hogan J, Wannous H, Aoun B, Decramer S, Deschênes G, Ulinski T (2014) Even mild cases of paediatric Henoch–Schönlein purpura nephritis show significant long-term proteinuria. Acta Paediatr. doi:10.1111/apa.12723 PubMed Tudorache E, Azema C, Hogan J, Wannous H, Aoun B, Decramer S, Deschênes G, Ulinski T (2014) Even mild cases of paediatric Henoch–Schönlein purpura nephritis show significant long-term proteinuria. Acta Paediatr. doi:10.​1111/​apa.​12723 PubMed

go back to reference Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martín J, Gonzalez-Gay MA (2005) A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 32:1737–1741PubMed Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martín J, Gonzalez-Gay MA (2005) A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 32:1737–1741PubMed

go back to reference Zeng HS, Xiong XY, Chen YY, Luo XP (2009) Gene polymorphism of vascular endothelial growth factor in children with Henoch–Schönlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 11:417–421PubMed Zeng HS, Xiong XY, Chen YY, Luo XP (2009) Gene polymorphism of vascular endothelial growth factor in children with Henoch–Schönlein purpura nephritis. Zhongguo Dang Dai Er Ke Za Zhi 11:417–421PubMed

go back to reference Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 8 gene polymorphism is associated with increased risk of nephritis in cutaneous vasculitis. J Rheumatol 29:2367–2370PubMed

go back to reference Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch–Schönlein purpura. J Rheumatol 29:1404–1407PubMed Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, Gonzalez-Gay MA (2002) Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch–Schönlein purpura. J Rheumatol 29:1404–1407PubMed

go back to reference Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stablile A (2005) Predictive factors of renal involvement or relapsing disease in children with Henoch–Schönlein purpura. Rheumatol Int 25:45–48CrossRefPubMed Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stablile A (2005) Predictive factors of renal involvement or relapsing disease in children with Henoch–Schönlein purpura. Rheumatol Int 25:45–48CrossRefPubMed

go back to reference de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA (2007) Renal involvement in Henoch–Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J) 83:259–266 de Almeida JL, Campos LM, Paim LB, Leone C, Koch VH, Silva CA (2007) Renal involvement in Henoch–Schönlein purpura: a multivariate analysis of initial prognostic factors. J Pediatr (Rio J) 83:259–266

go back to reference Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, Ormala T, Turtinen J, Nuutinen M (2006) Early prednisone therapy in Henoch–Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247CrossRefPubMed

go back to reference Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch–Schönlein purpura. BMC Med 2:7CrossRefPubMedCentralPubMed Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch–Schönlein purpura. BMC Med 2:7CrossRefPubMedCentralPubMed

go back to reference Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM (2009) Prevention and treatment of renal disease in Henoch–Schönlein purpura: a systematic review. Arch Dis Child 94:132–137CrossRefPubMed Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM (2009) Prevention and treatment of renal disease in Henoch–Schönlein purpura: a systematic review. Arch Dis Child 94:132–137CrossRefPubMed